1887

oa SA Pharmaceutical Journal - Biological drugs in breast cancer : increasing understanding for the pharmacist : review

 

Abstract

Cancer in South Africa is an emerging health problem, with breast cancer being a leading cancer in women. The medical treatment of breast cancer was solely reliant on cytotoxic chemotherapy for many years. A greater understanding of the underlying biology of breast cancer has resulted in the identification of a number of molecular targets and the development of novel therapeutic agents. Thus, treatment has evolved over the past decade into a more target-directed approach with the use of biological drugs. The three currently available biological drugs registered in South Africa for use in breast cancer include trastuzumab (Herceptin®), bevacizumab (Avastin®) and lapatinib (Tykerb®). This article briefly discusses their role in targeting breast cancer.

Loading

Article metrics loading...

/content/mp_sapj/81/8/EJC161384
2014-09-01
2016-12-03
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error